Vertex Pharmaceuticals - 30 Year Stock Price History | VRTX

Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits. The latest closing stock price for Vertex Pharmaceuticals as of September 17, 2021 is 188.30.
  • The all-time high Vertex Pharmaceuticals stock closing price was 303.10 on July 20, 2020.
  • The Vertex Pharmaceuticals 52-week high stock price is 280.99, which is 49.2% above the current share price.
  • The Vertex Pharmaceuticals 52-week low stock price is 184.78, which is 1.9% below the current share price.
  • The average Vertex Pharmaceuticals stock price for the last 52 weeks is 216.09.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Vertex Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 209.0434 229.4300 241.3100 187.1000 188.3000 -20.33%
2020 251.5545 219.4500 303.1000 199.7700 236.3400 7.94%
2019 184.7418 164.0800 223.9100 163.7300 218.9500 32.13%
2018 167.4049 152.9100 192.7400 145.7200 165.7100 10.58%
2017 126.9038 74.8900 166.1100 74.8900 149.8600 103.42%
2016 88.1828 122.8900 123.4500 72.0200 73.6700 -41.45%
2015 123.7852 123.0700 141.4800 98.5000 125.8300 5.92%
2014 89.4849 73.8300 120.7800 62.4400 118.8000 59.89%
2013 68.0295 43.6500 88.5100 43.6500 74.3000 77.33%
2012 47.3818 32.2300 64.8500 32.2000 41.9000 26.17%
2011 44.0248 35.9900 58.0100 26.6000 33.2100 -5.20%
2010 36.8595 44.2400 44.2400 32.1500 35.0300 -18.25%
2009 33.6777 30.6900 43.5500 26.2300 42.8500 41.05%
2008 25.9329 23.1500 34.6800 14.5900 30.3800 30.78%
2007 31.3792 36.9000 40.5600 23.2300 23.2300 -37.92%
2006 35.8992 27.9000 45.1200 27.9000 37.4200 35.24%
2005 16.3817 10.2400 28.9200 8.8300 27.6700 161.78%
2004 10.0132 10.5000 11.9100 8.1700 10.5700 2.13%
2003 12.7675 16.3600 16.4000 8.0000 10.3500 -34.70%
2002 20.1402 24.5400 31.6100 12.9500 15.8500 -35.54%
2001 38.1837 63.1300 74.1900 16.5200 24.5900 -65.61%
2000 51.5357 18.7500 97.2500 16.7500 71.5000 308.57%
1999 13.1561 14.7200 17.5450 9.9400 17.5000 17.65%
1998 13.7489 16.6900 19.6250 7.6250 14.8750 -9.85%
1997 18.9003 19.1250 25.5650 12.8750 16.5000 -18.01%
1996 14.7045 13.0000 20.1250 11.0000 20.1250 51.89%
1995 8.4467 7.5000 13.2500 6.3750 13.2500 76.67%
1994 7.1147 9.0600 9.6250 5.2500 7.5000 -18.92%
1993 5.5591 5.1250 9.3750 3.3750 9.2500 89.74%
1992 5.3817 7.5000 8.6250 3.3750 4.8750 -33.90%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $48.850B $6.206B
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $173.588B 53.62
Bristol Myers Squibb (BMY) United States $136.238B 9.07
Amgen (AMGN) United States $124.575B 13.49
CSL (CSLLY) Australia $102.379B 0.00
Gilead Sciences (GILD) United States $89.785B 8.68
BioNTech SE (BNTX) Germany $87.107B 18.80
Regeneron Pharmaceuticals (REGN) United States $69.722B 11.97
Illumina (ILMN) United States $65.576B 74.50
Biogen (BIIB) United States $44.738B 12.28
BeiGene (BGNE) Cayman Islands $37.427B 0.00
Seagen (SGEN) United States $28.420B 47.92
Genmab (GMAB) Denmark $28.322B 69.55
Genmab (GNMSF) Denmark $27.553B 68.87
Horizon Therapeutics Public (HZNP) Ireland $24.783B 23.49
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.622B 0.00
Bio-Techne Corp (TECH) United States $20.882B 93.91
Exact Sciences (EXAS) United States $18.596B 0.00
Novavax (NVAX) United States $17.693B 0.00
ARGENX SE-ADR (ARGX) Netherlands $17.061B 0.00
Repligen (RGEN) United States $16.850B 128.41
Incyte (INCY) United States $16.781B 39.79
BioMarin Pharmaceutical (BMRN) United States $14.257B 102.32
Guardant Health (GH) United States $13.377B 0.00
QIAGEN (QGEN) Netherlands $12.389B 20.98
Zai Lab (ZLAB) China $12.273B 0.00
Intellia Therapeutics (NTLA) United States $11.559B 0.00
CureVac (CVAC) Germany $10.301B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.489B 24.37
Ascendis Pharma (ASND) Denmark $9.109B 0.00
Mirati Therapeutics (MRTX) United States $8.985B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $8.829B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.380B 0.00
Vir Biotechnology (VIR) United States $7.124B 0.00
Sarepta Therapeutics (SRPT) United States $6.897B 0.00
Beam Therapeutics (BEAM) United States $6.828B 0.00
Fate Therapeutics (FATE) United States $6.815B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.666B 0.00
Exelixis (EXEL) United States $6.528B 71.45
Denali Therapeutics (DNLI) United States $6.426B 182.17
Legend Biotech (LEGN) United States $6.343B 0.00
Blueprint Medicines (BPMC) United States $6.209B 17.52
Twist Bioscience (TWST) United States $6.001B 0.00
Halozyme Therapeutics (HALO) United States $5.984B 24.44
NeoGenomics (NEO) United States $5.942B 805.33
I-Mab (IMAB) China $5.838B 0.00
AbCellera Biologics (ABCL) $5.674B 0.00
Adaptive Biotechnologies (ADPT) United States $5.595B 0.00
Certara (CERT) United States $5.464B 0.00
Alkermes (ALKS) Ireland $4.858B 143.38
Arvinas (ARVN) United States $4.746B 0.00
Editas Medicine (EDIT) United States $4.314B 0.00
Reata Pharmaceuticals (RETA) United States $4.000B 0.00
Arena Pharmaceuticals (ARNA) United States $3.729B 0.00
SpringWorks Therapeutics (SWTX) United States $3.675B 0.00
Galapagos (GLPG) Belgium $3.646B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Prothena (PRTA) Ireland $3.405B 0.00
Kymera Therapeutics (KYMR) United States $3.213B 0.00
ALX Oncology Holdings (ALXO) United States $3.139B 0.00
Insmed (INSM) United States $3.086B 0.00
Emergent Biosolutions (EBS) United States $3.068B 7.40
Apellis Pharmaceuticals (APLS) United States $2.976B 0.00
Amicus Therapeutics (FOLD) United States $2.932B 0.00
Cytokinetics (CYTK) United States $2.830B 0.00
Intra-Cellular Therapies (ITCI) United States $2.795B 0.00
Heska (HSKA) United States $2.777B 532.37
ACADIA Pharmaceuticals (ACAD) United States $2.683B 0.00
Myriad Genetics (MYGN) United States $2.632B 0.00
Arcus Biosciences (RCUS) United States $2.598B 0.00
Instil Bio (TIL) United States $2.544B 0.00
Celldex Therapeutics (CLDX) United States $2.528B 0.00
Morphic Holding (MORF) United States $2.460B 0.00
Sorrento Therapeutics (SRNE) United States $2.459B 0.00
C4 Therapeutics (CCCC) United States $2.420B 0.00
Ligand Pharmaceuticals (LGND) United States $2.414B 35.30
Vericel (VCEL) United States $2.410B 287.17
Seer (SEER) $2.288B 0.00
Atea Pharmaceuticals (AVIR) United States $2.171B 0.00
Alector (ALEC) United States $2.168B 0.00
Myovant Sciences (MYOV) United Kingdom $2.102B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.097B 35.72
Amarin (AMRN) Ireland $2.036B 515.00
Revance Therapeutics (RVNC) United States $2.000B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.988B 0.00
Castle Biosciences (CSTL) United States $1.946B 0.00
REGENXBIO (RGNX) United States $1.919B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.914B 0.00
Berkeley Lights (BLI) United States $1.819B 0.00
NGM Biopharmaceuticals (NGM) United States $1.781B 0.00
Global Blood Therapeutics (GBT) United States $1.749B 0.00
Inovio Pharmaceuticals (INO) United States $1.712B 0.00
Dynavax Technologies (DVAX) United States $1.709B 0.00
UniQure (QURE) Netherlands $1.696B 5.77
Dicerna Pharmaceuticals (DRNA) United States $1.680B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Codexis (CDXS) United States $1.654B 0.00
MorphoSys AG (MOR) Germany $1.643B 0.00
Nurix Therapeutics (NRIX) United States $1.599B 0.00
Ocugen (OCGN) United States $1.576B 0.00
Bionano Genomics (BNGO) United States $1.552B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.536B 0.00
Kadmon Holdings (KDMN) United States $1.505B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.478B 0.00
Genetron Holdings (GTH) China $1.463B 0.00
MaxCyte (MXCT) United States $1.442B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.434B 0.00
PureTech Health (PRTC) United States $1.413B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.408B 0.00
Inhibrx (INBX) United States $1.403B 0.00
Scholar Rock Holding (SRRK) United States $1.396B 0.00
Sangamo Therapeutics (SGMO) United States $1.388B 0.00
Zealand Pharma (ZEAL) Denmark $1.380B 0.00
Travere Therapeutics (TVTX) United States $1.367B 0.00
Agenus (AGEN) United States $1.359B 0.00
Coherus BioSciences (CHRS) United States $1.343B 0.00
Avid Bioservices (CDMO) United States $1.287B 262.25
Fulcrum Therapeutics (FULC) United States $1.242B 0.00
Bluebird Bio (BLUE) United States $1.238B 0.00
Repare Therapeutics (RPTX) Canada $1.169B 0.00
BioAtla (BCAB) United States $1.168B 0.00
RAPT THERAPTICS (RAPT) United States $1.164B 0.00
Precigen (PGEN) United States $1.132B 0.00
MannKind (MNKD) United States $1.131B 0.00
Northwest Biotherapeutics (NWBO) United States $1.129B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.124B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.114B 0.00
ImmunityBio (IBRX) United States $1.113B 0.00
Absci (ABSI) United States $1.108B 0.00
IDEAYA Biosciences (IDYA) United States $1.032B 0.00
Nkarta (NKTX) United States $1.030B 0.00
Prometheus Biosciences (RXDX) United States $1.016B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.986B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.963B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.943B 29.22
Immatics (IMTX) Germany $0.921B 0.00
Sutro Biopharma (STRO) United States $0.908B 0.00
Avidity Biosciences (RNA) United States $0.903B 0.00
BeyondSpring (BYSI) United States $0.896B 0.00
VBI Vaccines (VBIV) United States $0.847B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Protagonist Therapeutics (PTGX) United States $0.834B 0.00
Mesoblast (MESO) Australia $0.800B 0.00
Shattuck Labs (STTK) United States $0.799B 0.00
Akoya Biosciences (AKYA) United States $0.780B 0.00
Curis (CRIS) United States $0.777B 0.00
Precision BioSciences (DTIL) United States $0.766B 0.00
Cara Therapeutics (CARA) United States $0.764B 95.31
Amryt Pharma (AMYT) United Kingdom $0.760B 0.00
AnaptysBio (ANAB) United States $0.739B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.734B 0.00
Keros Therapeutics (KROS) United States $0.717B 0.00
Mersana Therapeutics (MRSN) United States $0.710B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.702B 12.79
MiMedx (MDXG) United States $0.688B 0.00
Adagene (ADAG) China $0.663B 0.00
G1 THERAPEUTICS (GTHX) United States $0.659B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.657B 0.00
Cellectis S.A (CLLS) France $0.656B 0.00
Pliant Therapeutics (PLRX) United States $0.656B 0.00
Seres Therapeutics (MCRB) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Innate Pharma S.A (IPHA) France $0.641B 0.00
Affimed (AFMD) Germany $0.628B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.618B 0.00
Spero Therapeutics (SPRO) United States $0.616B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
MeiraGTx Holdings (MGTX) United States $0.599B 0.00
ALBIREO PHARMA (ALBO) United States $0.593B 0.00
Epizyme (EPZM) United States $0.586B 0.00
Ambrx Biopharma (AMAM) United States $0.580B 0.00
VistaGen Therapeutics (VTGN) United States $0.575B 0.00
Clovis Oncology (CLVS) United States $0.573B 0.00
Anika Therapeutics (ANIK) United States $0.572B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.572B 0.00
Bolt Biotherapeutics (BOLT) United States $0.569B 0.00
Gritstone Bio (GRTS) United States $0.569B 0.00
DBV Technologies S.A (DBVT) France $0.562B 0.00
Vaccitech (VACC) United Kingdom $0.549B 0.00
Inventiva S.A (IVA) France $0.537B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.529B 0.00
Cel-Sci (CVM) United States $0.523B 0.00
Selecta Biosciences (SELB) United States $0.512B 0.00
AC Immune SA (ACIU) Switzerland $0.508B 0.00
Verastem (VSTM) United States $0.499B 0.00
Clene (CLNN) United States $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.488B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.487B 0.00
Bellus Health (BLU) Canada $0.472B 0.00
ChromaDex (CDXC) United States $0.462B 0.00
Compugen (CGEN) Israel $0.459B 0.00
Geron (GERN) United States $0.452B 0.00
Arbutus Biopharma (ABUS) United States $0.431B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.427B 0.00
Codiak BioSciences (CDAK) United States $0.427B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.425B 0.00
Oncobiologics (OTLK) United States $0.423B 0.00
Starpharma Holdings (SPHRY) Australia $0.412B 0.00
Cue Biopharma (CUE) United States $0.407B 0.00
SQZ Biotechnologies (SQZ) United States $0.406B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.406B 0.00
Clearside Biomedical (CLSD) United States $0.403B 0.00
BioDelivery Sciences (BDSI) United States $0.393B 12.09
ZIOPHARM Oncology Inc (ZIOP) United States $0.392B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.390B 0.00
Athenex (ATNX) United States $0.383B 0.00
ANI Pharmaceuticals (ANIP) United States $0.369B 10.07
Aeglea BioTherapeutics (AGLE) United States $0.367B 0.00
Cogent Biosciences (COGT) United States $0.358B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.354B 0.00
Neoleukin Therapeutics (NLTX) United States $0.350B 0.00
Cybin (CYBN) Canada $0.345B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
CytomX Therapeutics (CTMX) United States $0.341B 0.00
Fortress Biotech (FBIO) United States $0.339B 0.00
Prima BioMed (IMMP) Australia $0.334B 0.00
Opthea (OPT) Australia $0.333B 0.00
Athersys (ATHX) United States $0.333B 0.00
INmune Bio (INMB) United States $0.327B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.318B 0.00
Syros Pharmaceuticals (SYRS) United States $0.315B 0.00
Angion Biomedica (ANGN) United States $0.313B 0.00
AquaBounty Technologies (AQB) United States $0.313B 0.00
XOMA (XOMA) United States $0.290B 122.19
WAVE Life Sciences (WVE) Singapore $0.288B 0.00
Puma Biotechnology (PBYI) United States $0.281B 0.00
Beyond Air (XAIR) United States $0.278B 0.00
Checkpoint Therapeutics (CKPT) United States $0.278B 0.00
Cardiff Oncology (CRDF) United States $0.271B 0.00
IBio (IBIO) United States $0.268B 0.00
Kaleido Biosciences (KLDO) $0.248B 0.00
Frequency Therapeutics (FREQ) United States $0.247B 0.00
Kamada (KMDA) Israel $0.239B 19.89
AVEO Pharmaceuticals (AVEO) United States $0.237B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.234B 0.00
Adicet Bio (ACET) United States $0.229B 0.00
OVID THERAPEUTC (OVID) United States $0.229B 2.01
Adverum Biotechnologies (ADVM) United States $0.227B 0.00
Trevena (TRVN) United States $0.224B 0.00
Seelos Therapeutics (SEEL) United States $0.205B 0.00
Kala Pharmaceuticals (KALA) United States $0.203B 0.00
TELA Bio (TELA) United States $0.197B 0.00
NextCure (NXTC) United States $0.193B 0.00
ObsEva SA (OBSV) Switzerland $0.192B 0.00
Talis Biomedical (TLIS) United States $0.185B 0.00
OSMOTICA PHARM (OSMT) United States $0.180B 0.00
SESEN BIO, INC (SESN) United States $0.178B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
GENFIT S.A (GNFT) France $0.177B 0.00
HOOKIPA Pharma (HOOK) United States $0.176B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71
ATyr Pharma (LIFE) United States $0.174B 0.00
Synlogic (SYBX) United States $0.172B 0.00
ADMA Biologics Inc (ADMA) United States $0.171B 0.00
VolitionRX (VNRX) United States $0.168B 0.00
Aptinyx (APTX) United States $0.168B 0.00
Galena Biopharma (SLS) United States $0.167B 0.00
Catalyst Biosciences (CBIO) United States $0.162B 0.00
Erytech Pharma SA (ERYP) France $0.162B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Leap Therapeutics (LPTX) United States $0.158B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.157B 0.00
Biofrontera AG (BFRA) Germany $0.156B 0.00
Dyadic (DYAI) United States $0.151B 0.00
LogicBio Therapeutics (LOGC) United States $0.150B 0.00
TScan Therapeutics (TCRX) United States $0.150B 0.00
VTv Therapeutics (VTVT) United States $0.148B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.147B 0.00
Applied Genetic Technologies (AGTC) United States $0.147B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
Strongbridge Biopharma (SBBP) United States $0.144B 0.00
Nicox SA (NICXF) France $0.142B 0.00
Novogen (KZIA) Australia $0.140B 0.00
Liquidia Technologies (LQDA) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Cyclerion Therapeutics (CYCN) United States $0.135B 0.00
X4 Pharmaceuticals (XFOR) United States $0.131B 0.00
Evofem Biosciences (EVFM) United States $0.130B 0.00
Purple Biotech (PPBT) Israel $0.128B 0.00
Eton Pharmaceuticals (ETON) United States $0.126B 0.00
Orgenesis (ORGS) United States $0.125B 254.00
Exicure (XCUR) United States $0.124B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.122B 0.00
Abeona Therapeutics (ABEO) United States $0.121B 0.00
Voyager Therapeutics (VYGR) United States $0.118B 6.76
Eyenovia (EYEN) United States $0.117B 0.00
Entera Bio (ENTX) Israel $0.114B 0.00
Yumanity Therapeutics (YMTX) United States $0.114B 0.00
Viridian Therapeutics (VRDN) United States $0.112B 0.00
Palatin Technologies (PTN) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.105B 0.00
Cocrystal Pharma (COCP) United States $0.102B 0.00
Armata Pharmaceuticals (ARMP) United States $0.096B 0.00
Pluristem Therapeutics (PSTI) Israel $0.096B 0.00
Aadi Bioscience (AADI) United States $0.093B 0.00
Celsion (CLSN) United States $0.092B 0.00
Emmaus Life Sciences (EMMA) United States $0.085B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Zosano Pharma (ZSAN) United States $0.084B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Lumos Pharma (LUMO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
Statera Biopharma (STAB) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.081B 0.00
Liminal BioSciences (LMNL) Canada $0.081B 0.00
Aytu BioPharma (AYTU) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.079B 0.00
Evogene (EVGN) Israel $0.078B 0.00
Edesa Biotech (EDSA) Canada $0.078B 0.00
Advaxis (ADXS) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.076B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
ABVC BioPharma (ABVC) United States $0.070B 0.00
AIkido Pharma (AIKI) United States $0.070B 0.00
Longeveron (LGVN) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
Celyad SA (CYAD) Belgium $0.068B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Protalix BioTherapeutics (PLX) Israel $0.064B 0.00
AnPac Bio-Medical Science (ANPC) China $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
Enveric Biosciences (ENVB) United States $0.054B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.053B 0.00
Antibe Therapeutics (ATBPF) Canada $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 1.10
BioCardia (BCDA) United States $0.052B 0.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Forte Biosciences (FBRX) United States $0.051B 0.00
Windtree Therapeutics (WINT) United States $0.050B 0.00
ARIDIS PHARMACT (ARDS) United States $0.049B 0.00
Vallon Pharmaceuticals (VLON) United States $0.048B 0.00
Pulmatrix (PULM) United States $0.045B 0.00
Cyclo Therapeutics (CYTH) United States $0.044B 0.00
Soligenix (SNGX) United States $0.043B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.037B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.035B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Benitec Biopharma (BNTC) United States $0.032B 0.00
GeoVax Labs (GOVX) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
ZIVO Bioscience (ZIVO) United States $0.026B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00